A detailed history of Concord Wealth Partners transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 4,509 shares of TLRY stock, worth $7,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,509
Previous 4,509 -0.0%
Holding current value
$7,890
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$2.58 - $4.68 $11,633 - $21,102
4,509 New
4,509 $12,000
Q2 2022

Aug 04, 2022

BUY
$3.11 - $7.48 $1,555 - $3,740
500 Added 12.47%
4,509 $14,000
Q1 2022

Apr 20, 2022

SELL
$4.88 - $8.56 $1,019 - $1,789
-209 Reduced 4.95%
4,009 $31,000
Q4 2021

Jan 21, 2022

BUY
$7.03 - $13.03 $29,652 - $54,960
4,218 New
4,218 $30,000
Q3 2021

Nov 09, 2021

SELL
$11.11 - $17.84 $99 - $160
-9 Closed
0 $0
Q2 2021

Jul 29, 2021

BUY
$13.68 - $22.34 $123 - $201
9 New
9 $0

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.07B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.